11 Jun, 2021

Randomised, double-blind study in adults with major depressive disorder with inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine

Brintellix Clinical Summary – Montgomery et al
1-4
Download Brintellix Clinical Summary – Montgomery et al (978.71 KB)
001427_brintellix_montgomery_clinical_summary_2022-_digital_4pp_210x297_v1_02-fa-hr.pdf (978.71 KB)

AU-BRIN-0443. April 2024.

  • Brintellix
    Body

    Brintellix PBS information: This product is not listed on the PBS.

  • footer text
    Body

    Please review Approved Product Information before prescribing.
    Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:

    Brintellix PI

    Brintellix is a registered trademark of H. Lundbeck A/S.

Related

BROUGHT TO YOU BY

Lundbeck
© 2022 Lundbeck Australia

LUNDBECK AUSTRALIA PRODUCTS

Privacy and disclaimer

Cookies

Contact Us

Lundbeck Australia Pty Ltd 
1 Innovation road, Ground floor
NSW 2113, North Ryde, Australia
Phone +61 2 8669 1000
Fax +61 2 8669 1090

 

subscribe newsletter

Sign up for newsletter

This website is intended for viewing only by health care professionals in Australia.

All information provided within this site is intended only for residents of Australia.